| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 9,331,077 | |||
| Short-term investments | 42,859 | |||
| Accounts receivable, net | 343,469 | |||
| Inventories, net | 890,807 | |||
| Prepaids and other current assets | 191,755 | |||
| Total current assets | 10,799,967 | |||
| Property, equipment and rou assets, net | 881,549 | |||
| Intangible assets | 2,927,420 | |||
| Less accumulated amortization | 1,347,851 | |||
| Intangible assets, net | 1,579,569 | |||
| Other assets | 100,000 | |||
| Total assets | 13,361,085 | |||
| Accounts payable and accrued liabilities | 1,130,219 | |||
| Current portion of lease obligations | 424,765 | |||
| Total current liabilities | 1,554,984 | |||
| Lease obligations, net of current portion | 215,478 | |||
| Total liabilities | 1,770,462 | |||
| Common shares, no par value, unlimited authorized shares 2,604,186 and 2,002,186 as of september 30, 2025 and june 30, 2025, respectively, issued and outstanding | 91,806,396 | |||
| Additional paid-in capital | 38,620,449 | |||
| Accumulated deficit | -118,964,791 | |||
| Accumulated other comprehensive income | 128,569 | |||
| Total shareholders equity | 11,590,623 | |||
| Total liabilities and shareholders equity | 13,361,085 | |||
InMed Pharmaceuticals Inc. (INM)
InMed Pharmaceuticals Inc. (INM)